Plexus Q3 Earnings Beat Overshadowed by Mounting Free Cash Flow Pressure

What happened

Plexus reported a broad Q3 beat with revenue and EPS above expectations, and management raised the growth outlook, suggesting program wins are beginning to convert. However, the results were accompanied by a significant increase in working capital, pushing free cash flow well below prior run-rate and putting the full-year ~$100 million target at risk. The divergence between strong earnings and weak cash generation raises questions about the quality of growth and the sustainability of the current valuation. While the improved top-line trajectory supports the bull case, the market may now discount the stock if cash conversion doesn't improve. With shares trading near 28x trailing earnings, investors appear to be paying for flawless execution that the cash flow statement does not yet confirm.

Implication

The Q3 beat and raised outlook provide a glimmer of hope that the long-awaited growth acceleration is materializing. However, the simultaneous surge in working capital means that earnings are not converting into cash, a pattern that often precedes a reassessment of multiple. Until Plexus demonstrates it can translate sales growth into consistent free cash flow above $100 million, the stock's premium valuation leaves little room for disappointment. We would use any strength from the beat to trim positions above $190, while waiting for clearer evidence of cash flow normalization before adding to holdings. The risk remains skewed to the downside unless the next quarter delivers both sustained revenue momentum and improved cash conversion.

Thesis delta

The Q3 beat modestly improves the near-term growth outlook, but the sharp increase in working-capital needs intensifies the free cash flow concerns highlighted in the prior report. Consequently, the overall thesis remains cautious, and the potential sell rating is reinforced by the growing gap between reported earnings and underlying cash generation.